As the US Food and Drug Administration (FDA) comes increasingly under pressure to address the nation’s opioid crisis, patients across the US shared their perspectives on how state and federal actions have hindered access to pain relief medication during a meeting Monday.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,